ToolGen - Public Comps and Valuation Multiples

ToolGen Overview

About ToolGen

ToolGen Inc is a biotechnology company, which focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified, gRNA/Cas9, and recombinant Cas9 protein, which offers ready-to-use reagents for genome engineering experiments. The company also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services.

Founded

1999

HQ

Employees

Website

toolgen.com

Sectors

Genomics & Personalized Medicine
BioTech
DeepTech

Financials

Last FY Revenue $0.6M

Last FY EBITDA $7.2M

EV

$324M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

ToolGen Financials

See ToolGen valuation multiples based on analyst estimates

ToolGen P&L

In the most recent fiscal year, ToolGen reported revenue of $0.6M and EBITDA of $7.2M.

ToolGen expects next 12-month revenue of XXX and NTM EBITDA of XXX

See ToolGen valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$0.6M	XXX	XXX	XXX
Gross Profit	XXX	$0.5M	XXX	XXX	XXX
Gross Margin	XXX	76%	XXX	XXX	XXX
EBITDA	XXX	$7.2M	XXX	XXX	XXX
EBITDA Margin	XXX	1195%	XXX	XXX	XXX
EBIT	XXX	-$14.8M	XXX	XXX	XXX
EBIT Margin	XXX	-2446%	XXX	XXX	XXX
Net Profit	XXX	$4.2M	XXX	XXX	XXX
Net Margin	XXX	699%	XXX	XXX	XXX
Net Debt	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for ToolGen including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, ToolGen achieved $0.6M in revenue and $7.2M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$0.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$0.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	75.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$7.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	1195.0% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	-$14.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	-2446.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$4.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	699.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for ToolGen

This financial data table provides comprehensive performance metrics for ToolGen, a company based in South Korea. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, ToolGen reported $0.6M in total revenue.
Fiscal year EBITDA was $7.2M.
The company maintained a gross profit margin of 75.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 1195.0%.
Net profit margin reached 699.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for ToolGen. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

ToolGen Stock Performance

ToolGen has current market cap of KRW 502B (or $342M), and EV of KRW 477B (or $324M).

Market Cap Evolution

ToolGen Stock Data

As of December 4, 2025, ToolGen's stock price is KRW 58500 (or $40).

See ToolGen trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$324M	$342M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

ToolGen Valuation Multiples

ToolGen's trades at 535.0x EV/Revenue multiple, and 44.8x EV/EBITDA.

See valuation multiples for ToolGen and 15K+ public comps

ToolGen Financial Valuation Multiples

As of December 4, 2025, ToolGen has market cap of $342M and EV of $324M.

Equity research analysts estimate ToolGen's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

ToolGen's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$342M	XXX	$342M	XXX	XXX	XXX
EV (current)	$324M	XXX	$324M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	535.0x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	44.8x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	-21.9x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	80.5x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-28.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get ToolGen Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

ToolGen Margins & Growth Rates

ToolGen's revenue per employee in the last FY averaged $28K, while opex per employee averaged $0.7M for the same period.

ToolGen's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

ToolGen's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for ToolGen and other 15K+ public comps

ToolGen Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	1195%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$28K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.7M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	991%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	768%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	2522%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial